ARAY - アキュレイ (Accuray Incorporated) アキュレイ

 ARAYのチャート


 ARAYの企業情報

symbol ARAY
会社名 Accuray Inc (CA) (アキュレイ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 アキュウレイ(Accuray Incorporated)は放射線腫瘍会社である。同社はがん患者の治療のために放射線治療に使用される医療機器を開発、製造、販売する。同社の製品はCyberKnife Systems、TomoTherapy Systems、Radixact Delivery Treatment Platformを含む。同社の技術であるサイバーナイフとトモ治療システムは定位放射線手術(SRS)、定位体放射線療法(SBRT)、強度変調放射線療法(IMRT)、イメージガイド放射線療法(IGRT)、適応放射線療法等の治療法を提供する。CyberKnife Systemsは身体全体の各種の癌・腫瘍を治療するために使用されるロボットシステムである。CyberKnife Systemsは手術中にリアルタイムで腫瘍と患者の動きを追跡・検出・修正する。TomoTherapy Systemsには、TomoH、TomoHD、TomoHDAの設定オプションを備えたTomoTherapy Hシリーズが含まれる。   アキュレイは米国の放射線治療機器メ―カ―。放射線手術・療法システム、強度変調放射線療法システム、画像誘導放射線治療システムなどを開発・製造。主な製品には、ロボット放射線手術システム「サイバ―ナイフシステム」、治療装置システム「トモセラピ―システム」がある。本社はカリフォルニア州。   Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
本社所在地 1310 Chesapeake Terrace Sunnyvale CA 94089 USA
代表者氏名 Louis J. Lavigne ルイスJ.ラヴィーン
代表者役職名 Independent Chairperson of the Board
電話番号 +1 408-716-4600
設立年月日 33208
市場名 NASDAQ National Market System
ipoyear 2007年
従業員数 998人
url www.accuray.com
nasdaq_url https://www.nasdaq.com/symbol/aray
adr_tso
EBITDA EBITDA(百万ドル) 6.00800
終値(lastsale) 4.15
時価総額(marketcap) 358961554
時価総額 時価総額(百万ドル) 361.55650
売上高 売上高(百万ドル) 404.89700
企業価値(EV) 企業価値(EV)(百万ドル) 409.55050
当期純利益 当期純利益(百万ドル) 33.52100
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Accuray Incorporated revenues increased 6% to $404.9M. Net income before extraordinary items totaled $33.5M vs. loss of $29.6M. Revenues reflect Europe india Middle East and Africa segment increase of 15% to $120M Asia(Excl. Japan) segment increase of 23% to $72.9M. Net Income reflects Interest expense on debt decrease of 14% to $15M (expense).

 ARAYのテクニカル分析


 ARAYのニュース

   University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology  2020/09/01 11:30:00 PR Newswire
SUNNYVALE, Calif., Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital Città della Salute e della Scienza, in Turin, Italy have treated the first cancer patients in the Europe, India, Middle East and Africa…
   Global Medical Device Industry to 2025 - Featuring Abiomed, Accuray & Affectiva Among Others - ResearchAndMarkets.com  2020/08/21 15:40:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Medical Device Market by Device Type, Function, Durability, Therapeutic Segment, Risk Classification, Manufacture Method, Delivery/Acquisition, Operational Support Model, Connectivity and Region 2020 - 2025" report has been added to ResearchAndMarkets.com's offering. This medical device market report evaluates the market for both traditional and connected healthcare devices. The analysis includes medical device market sizing with a wide variety of segmentation incl
   Anne B. Le Grand Joins Accuray Board of Directors  2020/07/22 20:05:00 PR Newswire
SUNNYVALE, Calif., July 22, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020. In addition, she will serve on the Board's Nominating and Corporate Governance…
   Accuray To Report Fiscal Year-end 2020 Financial Results on August 13, 2020  2020/07/16 11:00:00 PR Newswire
SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020. Management will host a conference call to review the…
   Accuray Launches New CyberKnife® S7™ System  2020/06/17 11:30:00 PR Newswire
SUNNYVALE, Calif., June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife® S7™ System, an innovative device combining speed, advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and…
   Accuray To Report Fiscal Year-end 2020 Financial Results on August 13, 2020  2020/07/16 11:00:00 PR Newswire
SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020. Management will host a conference call to review the…
   Accuray Launches New CyberKnife® S7™ System  2020/06/17 11:30:00 PR Newswire
SUNNYVALE, Calif., June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife® S7™ System, an innovative device combining speed, advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and…
   Why Is Accuray (ARAY) Down 9.2% Since Last Earnings Report?  2020/05/28 15:30:59 Zacks Investment Research
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   How Accuray (ARAY) Stock Stands Out in a Strong Industry  2020/05/07 14:23:00 Zacks Investment Research
Accuray (ARAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   Will Accuray (ARAY) Gain on Rising Earnings Estimates?  2020/05/01 16:20:04 Zacks Investment Research
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
   Accuray Launches New CyberKnife® S7™ System  2020/06/17 11:30:00 PR Newswire
SUNNYVALE, Calif., June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife® S7™ System, an innovative device combining speed, advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and…
   Why Is Accuray (ARAY) Down 9.2% Since Last Earnings Report?  2020/05/28 15:30:59 Zacks Investment Research
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   How Accuray (ARAY) Stock Stands Out in a Strong Industry  2020/05/07 14:23:00 Zacks Investment Research
Accuray (ARAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   Will Accuray (ARAY) Gain on Rising Earnings Estimates?  2020/05/01 16:20:04 Zacks Investment Research
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
   What Makes Accuray (ARAY) a New Strong Buy Stock  2020/05/01 16:00:09 Zacks Investment Research
Accuray (ARAY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

 関連キーワード  (先端医療機器_テクノロジ― 米国株 アキュレイ ARAY Accuray Incorporated)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)